Table 2.
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Statistics | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CIP R% | Outpatient | 37.31 | 41.48 | 45.16 | 35.47 | 40.77 | 40.38 | 33.03 | 38.78 | 31.60 | 34.08 | n.s. (p = 0.641) |
Inpatient | 23.40 | 30.00 | 35.10 | 37.50 | 34.28 | 35.76 | 48.40 | 45.57 | 38.18 | 37.45 | ||
GEN R% | Outpatient | 27.69 | 34.09 | 25.81 | 24.53 | 27.69 | 27.40 | 21.10 | 28.14 | 18.80 | 19.10 | p = 0.0002 |
Inpatient | 26.24 | 13.33 | 14.42 | 13.31 | 16.96 | 15.41 | 17.99 | 16.14 | 16.36 | 13.62 | ||
SUM R% | Outpatient | 25.38 | 39.77 | 33.33 | 35.00 | 33.08 | 35.58 | 37.61 | 39.16 | 32.80 | 37.45 | n.s. (p = 0.399) |
Inpatient | 27.66 | 21.67 | 34.62 | 30.24 | 23.43 | 29.07 | 43.15 | 43.99 | 36.06 | 35.74 | ||
CRO R% | Outpatient | 23.85 | 31.25 | 37.63 | 26.74 | 36.15 | 35.10 | 27.52 | 35.36 | 27.20 | 25.09 | p = 0.132 |
Inpatient | 23.40 | 21.11 | 17.31 | 20.56 | 23.67 | 19.77 | 41.98 | 28.48 | 38.18 | 25.79 | ||
ESBL% | Outpatient | 26.74 | 30.00 | 31.73 | 25.69 | 34.22 | 26.00 | 23.22 | p = 0.243 | |||
Inpatient | 10.89 | 13.43 | 18.60 | 33.53 | 28.48 | 36.06 | 23.36 |
Values in italics represent the lowest resistance levels, boldface (peak) values correspond to the highest resistance levels in the study period; n.s.: not significant.